Summer Road LLC decreased its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 11.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,108,555 shares of the biopharmaceutical company’s stock after selling 1,471,102 shares during the quarter. Ocular Therapeutix accounts for approximately […]